198 related articles for article (PubMed ID: 23657825)
1. The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
Thomas SK; Hodson J; McIlroy G; Dhami A; Coleman JJ
Drug Saf; 2013 Jul; 36(7):557-64. PubMed ID: 23657825
[TBL] [Abstract][Full Text] [Related]
2. Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication.
Guérin A; Mody R; Carter V; Ayas C; Patel H; Lasch K; Wu E
PLoS One; 2016; 11(1):e0145504. PubMed ID: 26727382
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel and PPI interaction: clinically relevant or not?
Harrison RW; Mahaffey KW
Curr Cardiol Rep; 2012 Feb; 14(1):49-58. PubMed ID: 22090195
[TBL] [Abstract][Full Text] [Related]
4. [Impact of pharmacotherapeutic warnings on the prescription of clopidogrel and proton pump inhibitors in hospitalised patients].
Sánchez Ruiz-Gordoa M; Tenías Burillo JM; Ruiz Martín de la Torre R; Valenzuela Gámez JC
Farm Hosp; 2012; 36(4):250-5. PubMed ID: 22118768
[TBL] [Abstract][Full Text] [Related]
5. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
6. Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.
McIlroy G; Thomas SK; Coleman JJ
J Public Health (Oxf); 2015 Jun; 37(2):346-52. PubMed ID: 24681910
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice.
Stocks SJ; Kontopantelis E; Webb RT; Avery AJ; Burns A; Ashcroft DM
Drug Saf; 2017 Aug; 40(8):679-692. PubMed ID: 28439716
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011.
Guthrie B; Clark SA; Reynish EL; McCowan C; Morales DR
PLoS One; 2013; 8(7):e68976. PubMed ID: 23874832
[TBL] [Abstract][Full Text] [Related]
9. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016.
Perry LT; Bhasale A; Fabbri A; Lexchin J; Puil L; Joarder M; Mintzes B
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1054-1063. PubMed ID: 32696556
[TBL] [Abstract][Full Text] [Related]
10. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
[TBL] [Abstract][Full Text] [Related]
11. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
[TBL] [Abstract][Full Text] [Related]
12. Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.
Kwok CS; Loke YK
Drug Saf; 2012 Feb; 35(2):127-39. PubMed ID: 22204719
[TBL] [Abstract][Full Text] [Related]
13. Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.
Ruiter R; Visser LE; van Herk-Sukel MP; Geelhoed-Duijvestijn PH; de Bie S; Straus SM; Mol PG; Romio SA; Herings RM; Stricker BH
Drug Saf; 2012 Jun; 35(6):471-80. PubMed ID: 22540371
[TBL] [Abstract][Full Text] [Related]
14. Drug interaction: Clopidogrel and PPIs.
Med Lett Drugs Ther; 2017 Feb; 59(1515):39-40. PubMed ID: 28222065
[No Abstract] [Full Text] [Related]
15. The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study.
Sultana J; Fontana A; Giorgianni F; Pasqua A; Cricelli C; Spina E; Gambassi G; Ivanovic J; Ferrajolo C; Molokhia M; Ballard C; Sharp S; Sturkenboom M; Trifirò G
CNS Drugs; 2016 Nov; 30(11):1097-1109. PubMed ID: 27423216
[TBL] [Abstract][Full Text] [Related]
16. Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron.
Moriarty F; Razzaque S; McDowell R; Fahey T
J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30282903
[TBL] [Abstract][Full Text] [Related]
17. Decrease in Switches to 'Unsafe' Proton Pump Inhibitors After Communications About Interactions with Clopidogrel.
Kruik-Kollöffel WJ; van der Palen J; van Herk-Sukel MPP; Kruik HJ; Movig KLL
Clin Drug Investig; 2017 Aug; 37(8):787-794. PubMed ID: 28547741
[TBL] [Abstract][Full Text] [Related]
18. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
[TBL] [Abstract][Full Text] [Related]
19. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
Mol PG; Straus SM; Piening S; de Vries JT; de Graeff PA; Haaijer-Ruskamp FM
Drug Saf; 2010 Jun; 33(6):463-74. PubMed ID: 20486729
[TBL] [Abstract][Full Text] [Related]
20. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
